General Information

Stock Quote

ABMD (Common Stock)
Exchange NASDAQ (US Dollar)
Price   $97.14
Change (%)   Stock is Down  2.80  (2.80%)
Volume   922,343
Data as of 04/29/16 4:00 PM ET
Minimum 20 minute delay
Refresh quote

Corporate Profile

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.

Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

More>>

More »   Recent News

Date Title  
04/12/16

DANVERS, Mass., April 12, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Tuesday, May 3, 2016, the Company will release financial ...

04/12/16

DANVERS, Mass., April 12, 2016 (GLOBE NEWSWIRE) -- Abi...

04/07/16

DANVERS, Mass., April 07, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support t...

02/08/16

DANVERS, Mass., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today ann...

02/04/16

U.S. Patient Utilization Grew 45%, Year Over Year Abiomed Increases Fiscal Year 2016 Revenue Guidance DANVERS, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- ...